Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999-2008 (Q35949742)

11 August 2017

Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study: 1999-2008 (English)

1 reference

11 August 2017

9

John T Brooks

1 reference

11 August 2017

4

Frank J Palella

1 reference

11 August 2017

1

Kate Buchacz

1 reference

11 August 2017

3

Douglas J Ward

1 reference

11 August 2017

5

Joan S Chmiel

1 reference

11 August 2017

7

Bienvenido G Yangco

1 reference

11 August 2017

Rose Baker

2

1 reference

11 August 2017

Benjamin Young

series ordinal

6

1 reference

11 August 2017

Richard M Novak

series ordinal

8

1 reference

11 August 2017

14 March 2012

1 reference

AIDS Research and Treatment

11 August 2017

1 reference

11 August 2017

2012

1 reference

11 August 2017

230290

1 reference

Creative Commons Attribution 3.0 Unported

11 August 2017

start time

1 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Increased resilience to the development of drug resistance with modern boosted protease inhibitor-based highly active antiretroviral therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Emergence of drug resistance is associated with an increased risk of death among patients first starting HAART

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

The prevalence of antiretroviral drug resistance in the United States

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS).

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3349251

Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing.

11 July 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

Changes in the use of HIV antiretroviral resistance testing in a large cohort of U.S. patients, 1999 to 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

Long-term trends of HIV type 1 drug resistance prevalence among antiretroviral treatment-experienced patients in Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

The incidence rate of HIV type-1 drug resistance in patients on antiretroviral therapy: a nationwide population-based Danish cohort study 1999-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

Genotypic resistance and immunologic outcomes among HIV-1-infected women with viral failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

The impact of HIV drug resistance testing on changes to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

Detection of HIV drug resistance during antiretroviral treatment and clinical progression in a large European cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F230290

Triple-class antiretroviral drug resistance: risk and predictors among HIV-1-infected patients

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22611484

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22611484

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22611484

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1155/2012/230290

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

22611484

1 reference